Journal of Pediatric Health Care
Volume 24, Issue 2 , Pages 127-132 , March 2010

Individualizing Treatment for Adolescent Acne to Achieve Optimal Outcomes

  • Lara A. Clayton, MPAS, PA-C

      Affiliations

    • Corresponding Author InformationCorrespondence: Lara A. Clayton, MPAS, PA-C, Pediatric & Adolescent Dermatology, Rady Children's Hospital, 8010 Frost St, Suite 602, San Diego, CA 92123
  • ,
  • Wynnis L. Tom, MD

References 

  1. Baldwin HE. Tricks for improving compliance with acne therapy. Dermatologic Therapy. 2006;19:224–236
  2. Balkrishnan R, Kulkarni AS, Cayce K, Feldman SR. Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis. 2006;77:251–255
  3. Coates P, Vyakrnam S, Eady EA, Jones CE, Cove JH, Cunliffe WJ. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. British Journal of Dermatology. 2002;146:840–848
  4. Cunliffe WJ, Holland KT, Bojar R, Levy SF. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris. Clinical Therapeutics. 2002;24:1117–1133
  5. Ebling AM. Effectiveness of oral antibiotics and topical retinoid therapy in the treatment of acne in adolescents. Pediatric Nursing. 2001;27:410–411421
  6. Ellis CN, Leyden J, Katz HI, Goldfarb MT, Hickman J, Jones TM, et al. Therapeutic studies with a new combination benzoyl peroxide/clindamycin topical gel in acne vulgaris. Cutis. 2001;67(2 Suppl.):13–20
  7. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. Journal of the American Academy of Dermatology. 2003;49(1 Suppl.):S1–S37
  8. Goulden V. Guidelines for the management of acne vulgaris in adolescents. Paediatric Drugs. 2003;5:301–313
  9. Harper JC. Hormonal therapy for acne using oral contraceptive pills. Seminars in Cutaneous Medicine and Surgery. 2005;24:103–106
  10. Krowchuk DP. Managing adolescent acne: A guide for pediatricians. Pediatrics in Review. 2005;26:250–261
  11. Leyden JJ, Berger RS, Dunlap FE, Ellis CN, Connolly MA, Levy SF. Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris. American Journal of Clinical Dermatology. 2001;2:33–39
  12. Mareledwane NG. A randomized, open-label, comparative study of oral doxycycline 100 mg vs. 5% topical benzoyl peroxide in the treatment of mild to moderate acne vulgaris. International Journal of Dermatology. 2006;45:1438–1439
  13. Martin B, Meunier C, Montels D, Watts O. Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation. British Journal of Dermatology. 1998;139(Suppl. 52):8–11
  14. Nyirady J, Lucas C, Yusuf M, Mignone P, Wisniewski S. The stability of tretinoin in tretinoin gel microsphere 0.1%. Cutis. 2002;70:295–298
  15. Roebuck HL. Acne: Intervene early. The Nurse Practitioner. 2006;31:24–43
  16. Ross JI, Snelling AM, Carnegie E, Coates P, Cunliffe WJ, Bettoli V, et al. Antibiotic-resistant acne: Lessons from Europe. British Journal of Dermatology. 2003;148:467–478
  17. Shortridge E, Miller K. Contraindications to oral contraceptive use among women in the United States, 1999-2001. Contraception. 2007;75:355–360
  18. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. Journal of the American Academy of Dermatology. 2007;56:651–663
  19. Sturkenboom MC, Meier CR, Jick H, Stricker BH. Minocycline and lupuslike syndrome in acne patients. Archives of Internal Medicine. 1999;159:493–497
  20. Tan AW, Tan HH. Acne vulgaris: A review of antibiotic therapy. Expert Opinion on Pharmacotherapy. 2005;6:409–418
  21. Tan JK. Psychosocial impact of acne vulgaris: Evaluating the evidence. Skin Therapy Letter. 2004;9:1–39
  22. Taylor GA, Shalita AR. Benzoyl peroxide-based combination therapies for acne vulgaris: A comparative review. American Journal of Clinical Dermatology. 2004;5:261–265
  23. Thiboutot D, Gollnick H, Bettoli V, Dreno B, Kang S, Leyden J, et al. New insights into the management of acne: An update from the Global Alliance to Improve Outcomes in Acne Group. Journal of the American Academy of Dermatology. 2009;60:S1–S50
  24. Tschen E. Addressing patient variability: Clinical challenges in the initiation of acne treatment. Cutis. 2008;82(2 Suppl.):9–17
  25. Tschen EH, Katz HI, Jones TM, Monroe EW, Kraus SJ, Connolly MA, et al. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris. Cutis. 2001;67:165–169
  26. Warner GT, Plosker GL. Clindamycin/benzoyl peroxide gel: A review of its use in the management of acne. American Journal of Clinical Dermatology. 2002;3:349–360
  27. Yan AC. Current concepts in acne management. Adolescent Medicine Clinics. 2006;17:613–637
  28. Zaenglein AL, Thiboutot DM. Expert committee recommendations for acne management. Pediatrics. 2006;118:1188–1199

 Dermik Laboratories, a business of Sanofi-Aventis U.S. LLC, provided funding to Peloton Advantage, LLC, in order to support the development of this article. Peloton Advantage assisted with fact-checking, editing, and preparing the manuscript for submission. The opinions expressed in the current article are those of the authors. The authors received no honoraria or other form of financial support related to the development of this manuscript. Lara A. Clayton, MPAS, PA-C, and Wynnis L. Tom, MD, have no financial conflicts of interest to report.

PII: S0891-5245(09)00177-1

doi: 10.1016/j.pedhc.2009.06.003

Journal of Pediatric Health Care
Volume 24, Issue 2 , Pages 127-132 , March 2010